dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
qurevo 12.5/75/50mg 56 f.c. tabs. (moh hospitals only)
كيوريفو 12.5/75/50مجم 56 اقراص
ombitasvir+paritaprevir+ritonavir · 12.5/75/50mg
3250EGP
Available
Active ingredient
ombitasvir+paritaprevir+ritonavir
Strength
12.5/75/50mg
Form
tablet
Manufacturer
abbvie ltd.
Route
oral.solid

Uses

Antiviral combination used for treatment of chronic hepatitis C infection in appropriate patients.

Do not use if

Severe hepatic impairment or use with certain interacting medications.

Side effects

Fatigue, nausea, itching, insomnia, or elevated liver enzymes may occur.

Warnings

Monitor liver function and review potential drug interactions carefully.

How it works

Combines direct-acting antiviral agents targeting hepatitis C viral replication.

Storage

Store at room temperature.